Gideon, M.-K. (2022, February 23). Has Covid-19 Been Worse Than the 1918 Influenza Pandemic? Medium. https://gidmk.medium.com/has-covid-19-been-worse-than-the-1918-influenza-pandemic-1c3362f01bcc

Dr Ellie Murray, ScD 🇨🇦. (2022, February 18). If you have a little one who’s getting a vaccine soon but feeling a bit scared, this new book from @JanZauzmer is quite cute & might help them preview the experience. #VaccinesSaveLives https://t.co/MRngUYWsOJ [Tweet]. @EpiEllie. https://twitter.com/EpiEllie/status/1494695602248200198

Spinney, L. (2022). Pandemics disable people—The history lesson that policymakers ignore. Nature, 602(7897), 383–385. https://doi.org/10.1038/d41586-022-00414-x

The pelisse, a popular garment most recently revived through the iconic yellow model worn by Ana Taylor-Joy in Autumn de Wilde’s Emma (2020), might be included as a footnote in the twin history of fashion and ecological degradation.

By donning a pelisse, Mrs. Allen and Mrs. Thorpe, whatever their rivalries, were both at the cusp of early nineteenth-century fashion. Austen herself owned at least two pelisses, as historian Hilary Davidson has demonstrated. The pelisse, an overdress, was developed partly in response to the new Empire-period silhouette and partly due the “muslin disease” or influenza that ailed young women wearing fashionable lightweight fabrics in freezing weather.

In the colder months, pelisses could be lined with fur, so Mrs. Allen’s observation that Mrs. Thorpe’s lace is not as handsome would indicate that this scene takes place in the warmer months. The pelisse’s popularity led it to replace the fur cloaks of the earlier eighteenth century. Soon, though, pelisses themselves would be replaced with fur coats, which gained popularity throughout the nineteenth century, reaching a high point in the 1850s. Their popularity was in large part due to new methods of processing fur, which made it more supple (Fashioned 86). The consumption of fur and sealskin jackets, as well as feathers and cotton, throughout the period would lead to the devastation (e.g., India’s cotton industry) of ecosystems (71).

As we read these lines, then, we are reminded, of Austen’s critical eye for the consumer habits of her time. Although her critique here pertains to petty fashion rivalry, when reading about fashion items in her novels, we might find ourselves considering not only how little our fashion rivalries have changed but also how fashion and environmental degradation are historically linked.

For more on the pelisse, the spencer, and muslin, head over to Austenprose to read Hilary Davidson's post on Regency fashion in Emma (2020).

Works Cited

Kadambari, S., Goldacre, R., Morris, E., Goldacre, M. J., & Pollard, A. J. (2022). Indirect effects of the covid-19 pandemic on childhood infection in England: Population based observational study. BMJ, 376, e067519. https://doi.org/10.1136/bmj-2021-067519

David Spiegelhalter. (2022, January 6). Good news: Admissions for flu not quite as tiny as last year, but close. Https://gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2021-to-2022-season https://t.co/YILvkQ4Vqu [Tweet]. @d_spiegel. https://twitter.com/d_spiegel/status/1479139047515856901

Ro, C. (2021, November 1). Why mandatory vaccination is nothing new. https://www.bbc.com/future/article/20211029-why-mandatory-vaccination-is-nothing-new

Monto, A. S. (2021). The Future of SARS-CoV-2 Vaccination—Lessons from Influenza. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMp2113403

Influenza vaccines need to be updated yearly to counter (1) waning immunity and (2) antigenic drift.

Antigenic drift is monitored globally and the WHO makes recommendations for the updates.

The goal of influenza vaccines is to prevent severe complications and to reduce outbreaks — not to prevent them.

As many as 70% of some age groups get influenza vaccines.

Vaccine effectiveness for influenza vaccines for symptomatic infection is never higher than 50-60% and some years it is much slower.

Ling, M., Kothe, E. J., & Mullan, B. A. (2019). Predicting intention to receive a seasonal influenza vaccination using Protection Motivation Theory. Social Science & Medicine, 233, 87–92. https://doi.org/10.1016/j.socscimed.2019.06.002

Chan, M. S., Jamieson, K. H., & Albarracin, D. (2020). Prospective associations of regional social media messages with attitudes and actual vaccination: A big data and survey study of the influenza vaccine in the United States. Vaccine, 38(40), 6236–6247. https://doi.org/10.1016/j.vaccine.2020.07.054

Ortiz, J. R., & Neuzil, K. M. (2019). Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines. The Journal of Infectious Diseases, 219(Supplement_1), S97–S106. https://doi.org/10.1093/infdis/jiz024

Okoli, G. N., Abou-Setta, A. M., Neilson, C. J., Chit, A., Thommes, E., & Mahmud, S. M. (2019). Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis. Gerontology and Geriatric Medicine, 5, 2333721419870345. https://doi.org/10.1177/2333721419870345

Flu Vaccination Coverage, United States, 2018–19 Influenza Season | FluVaxView | Seasonal Influenza (Flu) | CDC. (2019, September 25). https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm

Adam Kucharski. (2021, August 5). Reading with hindsight, some interesting details in this 2018 piece on the places that escaped the 1918 pandemic... 1/ https://t.co/QWobRtmGcU [Tweet]. @AdamJKucharski. https://twitter.com/AdamJKucharski/status/1423297060380442632

Taquet, M., Husain, M., Geddes, J. R., Luciano, S., & Harrison, P. J. (2021). Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases. MedRxiv, 2021.04.27.21256153. https://doi.org/10.1101/2021.04.27.21256153

(2021). Retrieved 2 July 2021, from https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/988458/Weekly_Flu_and_COVID-19_report_w20_v2.pdf

ECDC (2020) Systemic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of lab-confirmed flu in individuals aged 18 and over Available at: https://www.ecdc.europa.eu/sites/default/files/documents/seasonal-influenza-vaccines-systematic-review-efficacy.pdf

Feng, L., Zhang, T., Wang, Q., Xie, Y., Peng, Z., Zheng, J., Qin, Y., Zhang, M., Lai, S., Wang, D., Feng, Z., Li, Z., & Gao, G. F. (2021). Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nature Communications, 12(1), 3249. https://doi.org/10.1038/s41467-021-23440-1

Lytras, T., Kopsachilis, F., Mouratidou, E., Papamichail, D., & Bonovas, S. (2015). Interventions to increase seasonal influenza vaccine coverage in healthcare workers: A systematic review and meta-regression analysis. Human Vaccines & Immunotherapeutics, 12(3), 671–681. https://doi.org/10.1080/21645515.2015.1106656

Maltezou, H. C., Theodoridou, K., Ledda, C., Rapisarda, V., & Theodoridou, M. (2019). Vaccination of healthcare workers: Is mandatory vaccination needed? Expert Review of Vaccines, 18(1), 5–13. https://doi.org/10.1080/14760584.2019.1552141

Cohen, S. (2020). Psychosocial Vulnerabilities to Upper Respiratory Infectious Illness: Implications for Susceptibility to Coronavirus Disease 2019 (COVID-19). Perspectives on Psychological Science, 1745691620942516. https://doi.org/10.1177/1745691620942516

Miller, E., Andrews, N., Stellitano, L., Stowe, J., Winstone, A. M., Shneerson, J., & Verity, C. (2013). Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: Retrospective analysis. BMJ, 346, f794. https://doi.org/10.1136/bmj.f794

Moyer, M. W. (n.d.). A Flu Shot Might Reduce Coronavirus Infections, Early Research Suggests. Scientific American. Retrieved February 23, 2021, from https://www.scientificamerican.com/article/a-flu-shot-might-reduce-coronavirus-infections-early-research-suggests/

Institute of Medicine (US) Forum on Medical and Public Health Preparedness for Catastrophic Events. (2010). The 2009 H1N1 Influenza Vaccination Campaign: Summary of a Workshop Series. National Academies Press (US). http://www.ncbi.nlm.nih.gov/books/NBK54185/

Seasonal flu vaccine uptake in healthcare workers: Winter 2019 to 2020. (n.d.). GOV.UK. Retrieved April 8, 2021, from https://www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-healthcare-workers-winter-2019-to-2020

Seasonal flu vaccine uptake in GP patients: Winter 2019 to 2020. (n.d.). GOV.UK. Retrieved April 8, 2021, from https://www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-gp-patients-winter-2019-to-2020

Nsoesie, E. O., Oladeji, O., Abah, A. S. A., & Ndeffo-Mbah, M. L. (2021). Forecasting influenza-like illness trends in Cameroon using Google Search Data. Scientific Reports, 11(1), 6713. https://doi.org/10.1038/s41598-021-85987-9

Fabry, P., Gagneur, A., & Pasquier, J.-C. (2011). Determinants of A (H1N1) vaccination: Cross-sectional study in a population of pregnant women in Quebec. Vaccine, 29(9), 1824–1829. https://doi.org/10.1016/j.vaccine.2010.12.109

Wong, L. P., & Sam, I.-C. (2010). Factors influencing the uptake of 2009 H1N1 influenza vaccine in a multiethnic Asian population. Vaccine, 28(28), 4499–4505. https://doi.org/10.1016/j.vaccine.2010.04.043

Uscher-Pines, L., Maurer, J., & Harris, K. M. (2011). Racial and Ethnic Disparities in Uptake and Location of Vaccination for 2009-H1N1 and Seasonal Influenza. American Journal of Public Health, 101(7), 1252–1255. https://doi.org/10.2105/AJPH.2011.300133

Rachiotis, G., Mouchtouri, V. A., Kremastinou, J., Gourgoulianis, K., & Hadjichristodoulou, C. (2010). Low acceptance of vaccination against the 2009 pandemic influenza A(H1N1) among healthcare workers in Greece. Eurosurveillance, 15(6), 19486. https://doi.org/10.2807/ese.15.06.19486-en

Final estimates for 2009–10 Seasonal Influenza and Influenza A (H1N1) 2009 Monovalent Vaccination Coverage – United States, August 2009 through May, 2010. | FluVaxView | Seasonal Influenza (Flu) | CDC. (2019, March 13). https://www.cdc.gov/flu/fluvaxview/coverage_0910estimates.htm

Godinho, C. A., Yardley, L., Marcu, A., Mowbray, F., Beard, E., & Michie, S. (2016). Increasing the intent to receive a pandemic influenza vaccination: Testing the impact of theory-based messages. Preventive Medicine, 89, 104–111. https://doi.org/10.1016/j.ypmed.2016.05.025

Myers, L. B., & Goodwin, R. (2011). Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health, 11(1), 15. https://doi.org/10.1186/1471-2458-11-15

Silverman, J. D., Hupert, N., & Washburne, A. D. (2020). Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abc1126

Milkman, K. L., Beshears, J., Choi, J. J., Laibson, D., & Madrian, B. C. (2011). Using implementation intentions prompts to enhance influenza vaccination rates. Proceedings of the National Academy of Sciences of the United States of America, 108(26), 10415–10420. https://doi.org/10.1073/pnas.1103170108

Schwarzinger, M., Flicoteaux, R., Cortarenoda, S., Obadia, Y., & Moatti, J.-P. (2010). Low Acceptability of A/H1N1 Pandemic Vaccination in French Adult Population: Did Public Health Policy Fuel Public Dissonance? PLOS ONE, 5(4), e10199. https://doi.org/10.1371/journal.pone.0010199

Sencer, D. J., & Millar, J. D. (2006). Reflections on the 1976 Swine Flu Vaccination Program. Emerging Infectious Diseases, 12(1), 29–33. https://doi.org/10.3201/eid1201.051007

Bish, A., Yardley, L., Nicoll, A., & Michie, S. (2011). Factors associated with uptake of vaccination against pandemic influenza: A systematic review. Vaccine, 29(38), 6472–6484. https://doi.org/10.1016/j.vaccine.2011.06.107

Wheelock, A., Miraldo, M., Thomson, A., Vincent, C., & Sevdalis, N. (2017). Evaluating the importance of policy amenable factors in explaining influenza vaccination: A cross-sectional multinational study. BMJ Open, 7(7), e014668. https://doi.org/10.1136/bmjopen-2016-014668

Wheelock, A., Miraldo, M., Thomson, A., Vincent, C., & Sevdalis, N. (2017). Evaluating the importance of policy amenable factors in explaining influenza vaccination: A cross-sectional multinational study. BMJ Open, 7(7), e014668. https://doi.org/10.1136/bmjopen-2016-014668

Doshi, P. (2018). Pandemrix vaccine: Why was the public not told of early warning signs? BMJ, 362, k3948. https://doi.org/10.1136/bmj.k3948

Kwon, Y., Cho, H.-Y., Lee, Y.-K., Bae, G.-R., & Lee, S.-G. (2010). Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate. Vaccine, 29(2), 161–165. https://doi.org/10.1016/j.vaccine.2010.10.063

Seale, H., Heywood, A. E., McLaws, M.-L., Ward, K. F., Lowbridge, C. P., Van, D., & MacIntyre, C. R. (2010). Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infectious Diseases, 10. https://doi.org/10.1186/1471-2334-10-99

Dolgin, E. (2021). How COVID unlocked the power of RNA vaccines. Nature, 589(7841), 189–191. https://doi.org/10.1038/d41586-021-00019-wq

Plans-Rubió, P. (2012). The vaccination coverage required to establish herd immunity against influenza viruses. Preventive Medicine, 55(1), 72–77. https://doi.org/10.1016/j.ypmed.2012.02.015

Pastor-Barriuso, R., Pérez-Gómez, B., Hernán, M. A., Pérez-Olmeda, M., Yotti, R., Oteo-Iglesias, J., Sanmartín, J. L., León-Gómez, I., Fernández-García, A., Fernández-Navarro, P., Cruz, I., Martín, M., Delgado-Sanz, C., Larrea, N. F. de, Paniagua, J. L., Muñoz-Montalvo, J. F., Blanco, F., Larrauri, A., & Pollán, M. (2020). Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: Nationwide seroepidemiological study. BMJ, 371, m4509. https://doi.org/10.1136/bmj.m4509

Poland, G. A. (2010). The 2009–2010 influenza pandemic: Effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine, 28, D3–D13. https://doi.org/10.1016/j.vaccine.2010.08.024

Here’s what we know about the new variant of coronavirus | Sharon Peacock. (2020, December 22). The Guardian. http://www.theguardian.com/commentisfree/2020/dec/22/new-variant-coronavirus-genomic-sars-cov-2-pandemic

Baker, R. E., Park, S. W., Yang, W., Vecchi, G. A., Metcalf, C. J. E., & Grenfell, B. T. (2020). The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proceedings of the National Academy of Sciences, 117(48), 30547–30553. https://doi.org/10.1073/pnas.2013182117

Tirrell, M. (2021, January 21). A year into the Covid crisis, scientists explain what we learned—And what we got wrong. CNBC. https://www.cnbc.com/2021/01/21/covid-19-what-we-learned-since-the-first-us-case-was-confirmed.html

Nyhan, B., Reifler, J., Richey, S., & Freed, G. L. (2014). Effective Messages in Vaccine Promotion: A Randomized Trial. Pediatrics, 133(4), e835–e842. https://doi.org/10.1542/peds.2013-2365

Jamison, A. M., Quinn, S. C., & Freimuth, V. S. (2019). “You don’t trust a government vaccine”: Narratives of Institutional Trust and Influenza Vaccination among African American and White Adults. Social Science & Medicine (1982), 221, 87–94. https://doi.org/10.1016/j.socscimed.2018.12.020

Risk perceptions: Assessment and relationship to influenza vaccination. - PsycNET. (n.d.). Retrieved January 28, 2021, from https://content.apa.org/record/2007-03487-003

Schmid, P., Rauber, D., Betsch, C., Lidolt, G., & Denker, M.-L. (2017). Barriers of Influenza Vaccination Intention and Behavior – A Systematic Review of Influenza Vaccine Hesitancy, 2005 – 2016. PLoS ONE, 12(1). https://doi.org/10.1371/journal.pone.0170550

Peek, K. (n.d.). Flu Season Never Came to the Southern Hemisphere. Scientific American. Retrieved October 5, 2020, from https://www.scientificamerican.com/article/flu-season-never-came-to-the-southern-hemisphere/

LMU Magazine. (2020, May 14). Shira Shafir ’99. https://magazine.lmu.edu/podcasts/shira-shafir-99/

Hoffman, J. (2020, August 16). Fearing a ‘Twindemic,’ Health Experts Push Urgently for Flu Shots. The New York Times. https://www.nytimes.com/2020/08/16/health/coronavirus-flu-vaccine-twindemic.html

Du, Z., Javan, E., Nugent, C., Cowling, B. J., & Meyers, L. A. (2020). Using the COVID-19 to influenza ratio to estimate early pandemic spread in Wuhan, China and Seattle, US. EClinicalMedicine, 0(0). https://doi.org/10.1016/j.eclinm.2020.100479

Clay, K., Lewis, J. A., Severnini, E. R., & Wang, X. (2020). The Value of Health Insurance during a Crisis: Effects of Medicaid Implementation on Pandemic Influenza Mortality (Working Paper No. 27120; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27120

Guimbeau, A., Menon, N., & Musacchio, A. (2020). The Brazilian Bombshell? The Long-Term Impact of the 1918 Influenza Pandemic the South American Way (Working Paper No. 26929; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w26929

Lin, P. Z., & Meissner, C. M. (2020). A Note on Long-Run Persistence of Public Health Outcomes in Pandemics (Working Paper No. 27119; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27119

Barro, R. J. (2020). Non-Pharmaceutical Interventions and Mortality in U.S. Cities during the Great Influenza Pandemic, 1918-1919 (Working Paper No. 27049; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27049

Barro, Robert J, José F Ursúa, and Joanna Weng. ‘The Coronavirus and the Great Influenza Pandemic: Lessons from the “Spanish Flu” for the Coronavirus’s Potential Effects on Mortality and Economic Activity’. Working Paper. Working Paper Series. National Bureau of Economic Research, March 2020. https://doi.org/10.3386/w26866.

Bodenhorn, Howard. ‘Business in a Time of Spanish Influenza’. Working Paper. Working Paper Series. National Bureau of Economic Research, July 2020. https://doi.org/10.3386/w27495.

Petersen, E., Koopmans, M., Go, U., Hamer, D. H., Petrosillo, N., Castelli, F., Storgaard, M., Khalili, S. A., & Simonsen, L. (2020). Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30484-9

Bergstrom, C. T. (2020, June 14). "1. Another day, another blog post of #COVID19 misinformation making the rounds." Twitter. https://twitter.com/CT_Bergstrom/status/1272007583222513664

Scientific Pandemic Influenza Group on Modelling (SPI-M). (n.d.). GOV.UK. Retrieved June 14, 2020, from https://www.gov.uk/government/groups/scientific-pandemic-influenza-subgroup-on-modelling

Chen, C. (2020, April 28). What Antibody Studies Can Tell You—And More Importantly, What They Can’t. ProPublica. https://www.propublica.org/article/what-antibody-studies-can-tell-you-and-more-importantly-what-they-cant

Simpson, C. R., Thomas, B. D., Challen, K., De Angelis, D., Fragaszy, E., Goodacre, S., Hayward, A., Lim, W. S., Rubin, G. J., Semple, M. G., & Knight, M. (2020). The UK hibernated pandemic influenza research portfolio: Triggered for COVID-19. The Lancet Infectious Diseases, S1473309920303984. https://doi.org/10.1016/S1473-3099(20)30398-4

COVID-19—Eine Zwischenbilanz oder eine Analyse der Moral, der medizinischen Fakten, sowie der aktuellen und zukünftigen politischen Entscheidungen. (2020, April 7). DIE MITTELLÄNDISCHE ZEITUNG - FÜR MEHR DURCHBLICK. https://www.mittellaendische.ch/2020/04/07/covid-19-eine-zwischenbilanz-oder-eine-analyse-der-moral-der-medizinischen-fakten-sowie-der-aktuellen-und-zuk%C3%BCnftigen-politischen-entscheidungen/

Australian Government Department of Health (2020, April 1). Coronavirus (COVID-19) – Restrictions on entry into and visitors to aged care facilities [Text]. https://www.health.gov.au/resources/publications/coronavirus-covid-19-restrictions-on-entry-into-and-visitors-to-aged-care-facilities

Cohn, S. (2020 May 01). Face masks: What the Spanish flu can teach us about making them compulsory. The Conversation. http://theconversation.com/face-masks-what-the-spanish-flu-can-teach-us-about-making-them-compulsory-137648

Roland, L. T., Gurrola, J. G., Loftus, P. A., Cheung, S. W., & Chang, J. L. (2020). Smell and taste symptom‐based predictive model for COVID‐19 diagnosis. International Forum of Allergy & Rhinology, alr.22602. https://doi.org/10.1002/alr.22602

Lipsitch, M., Perlman, S., & Waldor, M. K. (2020). Testing COVID-19 therapies to prevent progression of mild disease. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30372-8

Bruine De Bruin, W., Fischhoff, B., Brilliant, L., & Caruso, D. (2006). Expert judgments of pandemic influenza risks. Global Public Health, 1(2), 179–194. https://doi.org/10.1080/17441690600673940

LePan, N. (2020, March 14). Visualizing the History of Pandemics. Visual Capitalist. https://www.visualcapitalist.com/history-of-pandemics-deadliest/